Cargando…
All‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practice: Madrid coinfection registry findings
We evaluated treatment outcomes in a prospective registry of human immunodeficiency virus/hepatitis C virus (HCV)–coinfected patients treated with interferon‐free direct‐acting antiviral agent–based therapy in hospitals from the region of Madrid between November 2014 and August 2016. We assessed sus...
Autores principales: | Berenguer, Juan, Gil‐Martin, Ángela, Jarrin, Inmaculada, Moreno, Ana, Dominguez, Lourdes, Montes, Marisa, Aldámiz‐Echevarría, Teresa, Téllez, María J., Santos, Ignacio, Benitez, Laura, Sanz, José, Ryan, Pablo, Gaspar, Gabriel, Alvarez, Beatriz, Losa, Juan E., Torres‐Perea, Rafael, Barros, Carlos, Martin, Juan V. San, Arponen, Sari, de Guzmán, María T., Monsalvo, Raquel, Vegas, Ana, Garcia‐Benayas, María T., Serrano, Regino, Gotuzzo, Luis, Menendez, María Antonia, Belda, Luis M, Malmierca, Eduardo, Calvo, María J., Cruz‐Martos, Encarnación, González‐García, Juan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055848/ https://www.ncbi.nlm.nih.gov/pubmed/29377274 http://dx.doi.org/10.1002/hep.29814 |
Ejemplares similares
-
FTO rs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients
por: Pineda-Tenor, Daniel, et al.
Publicado: (2014) -
Perinatal HCV Transmission Rate in HIV/HCV Coinfected women with access to ART in Madrid, Spain
por: Domínguez-Rodríguez, Sara, et al.
Publicado: (2020) -
Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis
por: Pérez-Latorre, Leire, et al.
Publicado: (2018) -
Soluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of Outcome
por: Aldámiz-Echevarría, Teresa, et al.
Publicado: (2016) -
HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1
por: Berenguer, Juan, et al.
Publicado: (2019)